Our latest Technologies
    CIS Pharma welcomes your interest in our innovations. We out-license pipeline technologies with a strong scientific and commercial rationale.

Rolf Schäfer, Corporate Strategy & Innovation
 
 

Cellophil™ amino-acid based polymers & drug delivery systems download
Cellophil™ is a platform of patented polymers with superior biocompatibility. Cellophil™ delivery systems are loaded with one or more active compounds with controlled release kinetics. Current developments are in the field of

- ophthalmology - drug delivery from conjunctiva to the back of the eye (ARVO)
- cardiovascular - dual drug eluting stents with differing release kinetics
- dermatology - sprayable dressings that enhance wound healing
- oncology - injectable and time-release anticancer drug delivery systems

Preservative-free multi-dose delivery systems download
The delivery system is designed for low and high viscosity formulations, from ophthalmic drops, ointments up to to skincare creams. Both small as well as large molecular entities can be dispensed from the system. The system is incorporated in various designs and its efficacy and safety is proven.

Biomimetic skin treatment based on plant stem cells
Applying advanced techniques of biotechnology, CIS Pharma has developed a proprietary anti-aging technology that offers pure biological actives. The technology is a platform for the development of a variety of dermatocosmetics and anti-aging treatments. The technology makes available a plant’s full range of active principles, stabilized with proprietary technology to achieve standard shelf life.